Search

Search Constraints

You searched for: Author/Creator Furst, Tomas

Search Results

2. A high TP53 mutation burden is a strong predictor of primary refractory mantle cell lymphoma. (30th August 2020)

3. Maintenance rituximab in newly diagnosed mantle cell lymphoma patients: a real world analysis from the Czech lymphoma study group registry†. Issue 3 (23rd February 2019)